CA-ALORICA-INC
24.1.2023 10:16:39 CET | Business Wire | Press release
Alorica Inc., a trusted leader in next-generation customer experience (CX) solutions, today announced its expansion plans into Africa and Europe through the launch of its operations in Cairo, Egypt and Łódź, Poland. As one of the largest business process outsourcers (BPO) globally with 100,000 employees across 17 countries and 24 years of CX experience—Alorica continues to scale and diversify its best-in-class workforce, now with a presence in these new markets. Setting up operations in Egypt and Poland further enables the digital CX company to meet the growing expectations of multinational companies to deliver industry-leading business outcomes including multilingual customer care, revenue generation, content management & content moderation, tech support and CX consulting. Alorica plans to open for business in both countries during second quarter of this year.
“Growth through Africa and Europe is key to our strategy of offering culturally and linguistically relevant support to well-established and emerging businesses worldwide,” said Greg Haller, Chief Executive Officer at Alorica. “Egypt and Poland have been on our radar as robust commercial markets with a strong talent pipeline. Our new operations will unlock career opportunities for local residents and create a distinct path to extend our solutions to clients in the region.”
With the expansion into Egypt and Poland, Alorica continues its investment into high-growth markets with scalable talent. Its experienced workforce offers CX support in over 30 languages to service brands in high-demand industries ranging from financial services, technology, travel & hospitality to e-commerce and retail among others. With existing operations of 1,000+ employees in Sofia, Bulgaria, the company will continue to leverage its innovative technologies to engage employees and customers through a combination of its work-at-home and on-site programs.
In Cairo, Alorica’s new contact center is strategically located in Sheikh Zayed City near top private universities, while its site in Łódź, Poland is in the heart of the city near Warsaw—accessible to high-caliber candidates. Both locations are equipped with numerous onsite amenities—accessible transportation, public services, retail stores, and more—while providing maximum efficiency for both brick-and-mortar and work-at-home operations that appeals to a multicultural and multilingual workforce.
Rooted in a people-first foundation, Alorica focuses on employee engagement as a critical driver of performance. The company prides itself on its socially responsible and inclusive work environment, which has resulted in record high employee satisfaction scores. A pioneer in versatile operating models that fosters flexibility, Alorica offers jobs around the globe across state-of the-art contact centers as well as through its work-at-home solution Alorica Anywhere and hybrid Connection Hubs—serving as important channels to link teams for collaboration, training and continuous improvement.
“Leveraging Alorica’s global scale and deep experience, we will provide localized service delivery to companies here in the region, while also enhancing EMEA’s reputation as the top outsourcing destination for customers everywhere,” said Alorica’s EMEA President Matt Sims. “I’m excited to bring Alorica’s mission-driven culture to Egypt and Poland as we hire and develop talented individuals from diverse backgrounds who are passionate about making lives better. As part of our corporate social responsibility, we are committed to not only doing business in the region, but also making an impact through our philanthropic work, people-focused programs and sustainability initiatives, benefiting the communities where our employees live and work. We’re looking forward to creating many jobs in these countries.”
The company continues to receive industry honors for its world-class vision and operational excellence—having been named a Leader in the 2022 Gartner Magic Quadrant for Customer Service BPO for the second consecutive year. Alorica has also garnered recognition as an employer of choice for its purposeful culture and employee engagement, winning awards such as Top Places to Work, Employer of the Year and Best in Biz, while also earning Great Place to Work® certifications for its operations in the Philippines and Guatemala.
To learn more about Alorica’s insanely great CX services in EMEA, email us at info@alorica.com.
About Alorica
Alorica creates insanely great digital customer experiences at scale. Our team of 100,000 solutionists, technologists and operators partner with global brands and disruptive innovators to deliver digitally-charged, tailored interactions customers crave. With a track record of creating long-term loyalty, Alorica brings actionable insights, proven processes and CX leadership to transform clients’ business needs, whether they’re focused on digital optimization, customer engagement or market expansion. Through strategic partnerships with best-in-breed technology, we design, integrate and optimize digital solutions personalized to reach clients’ most desired outcomes now and for the future. Alorica drives CX innovation for the best clients around the globe from its award-winning operations in 17 countries worldwide. To learn more, visit www.alorica.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230124005089/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
